跳至主要内容
临床试验/NCT02518204
NCT02518204已完成不适用

Validity of an Online Neurocognitive Test Battery, the Brain Performance Test (BPT), in Normal Healthy Adults

Lumos Labs, Inc.6 个研究点 分布在 1 个国家目标入组 229 人开始时间: 2015年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
229
试验地点
6
主要终点
Correlation coefficients (Pearson's r) of scaled scores of BPT subtests compared to scaled scores of their NP correlates at Time 1

研究概览

简要总结

The purpose of this study is to evaluate the concurrent validity between the Brain Performance Test (BPT) subtests and corresponding conventional in-person neuropsychological assessments (NP).

详细描述

This will be a multi-site, randomized, counterbalanced, two-period, two-sequence, validation study of the online, unsupervised Brain Performance Test (BPT). Over the course of 14 days, participants will complete two in-clinic visits during which they will complete both the BPT and in-person neuropsychological assessments (NP).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
70 Years 至 89 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • Native English speaker
  • Capable and willing to provide informed consent
  • Able to use a computer and mouse without assistance
  • Limited (< 3 days) or no experience with Lumosity.com
  • Limited (< 3 days) or no experience with other cognitive training programs (e.g., FitBrains, CogMed)
  • Willing to refrain from online cognitive training during the course of the study
  • No recent (<1 years) experience with either computer-based or in-person neuropsychological tests (e.g., WAIS-IV, WISC, Halstead-Reitan Battery, MATRICS, CogState, CNS Vital Signs)
  • Good general health assessed via self-reported online physical questionnaire and medical history questionnaire

排除标准

  • Illiterate or unable to understand written English sufficiently to comprehend study instructions and consent form
  • Uncorrected visual impairment (beyond that required to qualify for a California Driver's License) that may impact the ability to complete assessments (self-report or determined by the clinician)
  • Uncorrected auditory impairment that may impact the ability to complete assessments (self-report or determined by the clinician)
  • Self-reported clinical diagnosis for primary psychiatric or neurological disorder (e.g., schizophrenia, multiple sclerosis, attention deficit hyperactivity disorder, Parkinson's disease, epilepsy)
  • Self-reported history of concussion or traumatic brain injury, that is considered clinically significant in the opinion of the investigator (e.g. loss of consciousness ≤ 30 minutes)
  • Self-reported diagnosis of mental retardation or pervasive developmental disorder
  • Self-reported diagnosis of Mild Cognitive Impairment, Alzheimer's disease, or other dementia
  • Self-reported history of sustained substance or alcohol abuse or dependence, that is considered clinically significant in the opinion of the investigator (e.g. as defined by DSM-5)
  • Self-report that subject is currently taking an antipsychotic, antidepressant, anti-anxiety, or a cognitively-enhancing medication (e.g. Ritalin), or in the last 72 hours, narcotics for pain or other medications that may impact cognitive performance (e.g. sleeping medications/aides or cold/allergy medications)
  • Any other significant medical condition that could impact cognitive performance or result in cognitive impairment in the opinion of the investigator
  • Score <28 on the MMSE
  • Positive urine test for recent substance use on either testing day
  • Breath Alcohol Content of 0.01% or greater on either testing day

结局指标

主要结局

Correlation coefficients (Pearson's r) of scaled scores of BPT subtests compared to scaled scores of their NP correlates at Time 1

时间窗: 1 day

次要结局

  • Interclass correlations (ICC) of scaled scores of BPT subtests compared to scaled scores of their NP correlates at Time 1(1 day)
  • Correlation coefficients (Pearson's r and ICC) of BPT Grand Index and NP Overall Index at Time 1 and Time 2 as measures of reliability(2 weeks)
  • Correlation coefficients (Pearson's r and ICC) of raw and scaled scores of BPT subtests at Time 1 and Time 2 as measures of test-retest reliability(2 weeks)
  • Correlation coefficients (Pearson's r and ICC) of raw scores of BPT subtests compared to raw scores of their NP correlates at Time 1(1 day)
  • Correlation coefficients (Pearson's r and ICC) of BPT composite indices and NP composite indices at Time 1(1 day)
  • Correlation coefficients (Pearson's r and ICC) of composite indices of BPT and NP at Time 1 and Time 2 as measures of reliability(2 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验